Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 240

1.

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.

[No authors listed]

Contraception. 1996 Sep;54(3 Suppl):1S-106S. Review.

PMID:
8899264
[PubMed - indexed for MEDLINE]
2.

Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.

van Leeuwen FE.

Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Review.

PMID:
1801500
[PubMed - indexed for MEDLINE]
3.

Effect of endogenous and exogenous hormones on breast cancer: epidemiology.

Vessey MP.

Verh Dtsch Ges Pathol. 1997;81:493-501. Review.

PMID:
9474890
[PubMed - indexed for MEDLINE]
4.

Breast cancer risk: perception versus reality.

Westhoff CL.

Contraception. 1999 Jan;59(1 Suppl):25S-28S. Review.

PMID:
10342093
[PubMed - indexed for MEDLINE]
5.

Use of HRT and the subsequent risk of cancer.

Beral V, Banks E, Reeves G, Appleby P.

J Epidemiol Biostat. 1999;4(3):191-210; discussion 210-5. Review.

PMID:
10695959
[PubMed - indexed for MEDLINE]
6.

Exogenous progestins and breast cancer.

Stanford JL, Thomas DB.

Epidemiol Rev. 1993;15(1):98-107. Review.

PMID:
8405216
[PubMed - indexed for MEDLINE]
7.

Oral contraceptives and breast cancer: review of the epidemiologic literature.

Thomas DB.

Contraception. 1991 Jun;43(6):597-642. Review.

PMID:
1868735
[PubMed - indexed for MEDLINE]
8.

Weighing the evidence on the pill and breast cancer.

Johnson JH.

Fam Plann Perspect. 1989 Mar-Apr;21(2):89-92. Review.

PMID:
2653859
[PubMed - indexed for MEDLINE]
9.

Oral contraceptives and breast disease.

McGonigle KF, Huggins GR.

Fertil Steril. 1991 Nov;56(5):799-819. Review.

PMID:
1936311
[PubMed - indexed for MEDLINE]
10.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770
[PubMed - indexed for MEDLINE]
11.

The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.

Bernstein L.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):288-96. Review.

PMID:
16611204
[PubMed - indexed for MEDLINE]
12.

[Hormone replacement therapy in menopause and risk of breast cancer].

Clavel-Chapelon F, Hill C.

Presse Med. 2000 Oct 21;29(31):1688-93. Review. French.

PMID:
11094609
[PubMed - indexed for MEDLINE]
13.

Depo Provera. Position paper on clinical use, effectiveness and side effects.

Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.

Br J Fam Plann. 1999 Jul;25(2):69-76. Review. Erratum in: Br J Fam Plann 2000 Jan;26(1):52-3.

PMID:
10454658
[PubMed - indexed for MEDLINE]
14.

Long-term health risks and benefits of oral contraceptive use.

Peterson HB, Lee NC.

Obstet Gynecol Clin North Am. 1990 Dec;17(4):775-88. Review.

PMID:
2092241
[PubMed - indexed for MEDLINE]
15.

Risks of oral contraceptive use in women over 35.

Stenchever MA.

J Reprod Med. 1993 Dec;38(12 Suppl):1030-5. Review.

PMID:
8120860
[PubMed - indexed for MEDLINE]
16.

Oral contraceptives in relation to breast cancer.

Malone KE, Daling JR, Weiss NS.

Epidemiol Rev. 1993;15(1):80-97. Review.

PMID:
8405215
[PubMed - indexed for MEDLINE]
17.

Combined oral contraceptives: risks and benefits.

Thorogood M, Villard-Mackintosh L.

Br Med Bull. 1993 Jan;49(1):124-39. Review.

PMID:
8324603
[PubMed - indexed for MEDLINE]
18.
19.

Oral contraceptives and breast cancer.

Schlesselman JJ.

Am J Obstet Gynecol. 1990 Oct;163(4 Pt 2):1379-87. Review.

PMID:
2220962
[PubMed - indexed for MEDLINE]
20.

[Oral contraceptives and breast cancer].

Zoricić D, Ambrozić B, Perić D.

Lijec Vjesn. 1998 Dec;120(12):392-7. Review. Croatian.

PMID:
19658362
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk